| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $0 | — |
| SG&A Expense | $94K | +43.9% |
| Operating Income | -$94K | -43.9% |
| Interest Expense | $11K | +0.0% |
| Pre-tax Income | -$104K | -27.4% |
| Net Income | -$104K | -37.5% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $33K | — |
| Total Assets | $268K | +167.5% |
| Current Liabilities | $475K | -29.4% |
| Total Liabilities | $475K | -29.4% |
| Stockholders' Equity | -$207K | +63.8% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$166K | -182.0% |
| Financing Cash Flow | $300K | +200.0% |